Skip to content
ppharmaranks
Menu

Best treatments for chronic bronchitis

4 products may treat chronic bronchitis, spanning FDA drug classes such as anticholinergic, beta2-adrenergic agonist. The current highest-rated option is spiriva respimat. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 4 drugs we list for chronic bronchitis, 2 are available as lower-cost generics, spanning classes such as anticholinergic, beta2-adrenergic agonist. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for chronic bronchitis — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Top-rated picks for chronic bronchitis: 1. Spiriva Respimat · 2. Striverdi Respimat · 3. Spiriva

Top-rated treatments for chronic bronchitis, ranked by pharmaranks score
#DrugRatingPharmacy pays
172/100$354View →
272/100View →
370/100$354View →
4Not yet ratedView →

Narrow by drug class

Explore the class hubs: anticholinergic

Full ranking · 4 treatments

Frequently asked

What treats chronic bronchitis?
Our catalog lists 4 products that may treat chronic bronchitis, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is spiriva respimat.
What is the best-rated treatment for chronic bronchitis?
By our independent recall-safety rating — not an efficacy measure — spiriva respimat ranks highest among the products we list for chronic bronchitis. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat chronic bronchitis?
Treatments for chronic bronchitis span FDA drug classes including anticholinergic, beta2-adrenergic agonist. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.